Vaxart Inc. Stock
Price
Target price
-
-
-
-
-
?0.000
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vaxart Inc. Stock
The community is currently still undecided about Vaxart Inc. with 1 Buy predictions and 0 Sell predictions.
For the coming years our community has positive and negative things to say abot the Vaxart Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Vaxart Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vaxart Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vaxart Inc. | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -2.370% | 2.976% | 9.494% | 7.453% | 4.217% | 13.816% | -58.563% |
| Northwest Biotherapeutics Inc. | 0.000% | 3.333% | -6.627% | -23.267% | -24.757% | -68.238% | -84.500% |
| Achieve Life Sciences Inc. | -1.830% | 0.926% | 10.772% | 141.150% | 47.297% | 7.921% | -14.844% |
Comments
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AVIR provided by MarketBeat
News
Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now
Key Points
- Interested in Vaxart, Inc.? Here are five stocks we like better.
- Vaxart shareholders rejected the company’s say-on-pay proposal at its 2026 annual meeting, even as they re-elected
3 Stocks Under $5 With Strong Analyst Upside Potential
At a time when many investors are rotating out of speculative penny stocks, others continue to embrace the risk-reward dynamic. Stocks that trade for under $5 carry a certain amount of risk. Many